<DOC>
	<DOCNO>NCT01243814</DOCNO>
	<brief_summary>To compare therapeutic effect single intra-articular injection hyaluronate single intra-articular injection normal saline ( placebo ) osteoarthritis ankle .</brief_summary>
	<brief_title>A Double-blind RCT Single Dose Hyaluronan Treatment Osteoarthritis Ankle</brief_title>
	<detailed_description>This study randomize , prospective , double-blind ( blind observer ) , saline solution-controlled , parallel experimental design . The study device SUPARTZ ( Seikagaku Corporation , Tokyo , Japan ) brand sodium hyaluronate .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>To eligible , subject least 18 year old , pregnant , pain osteoarthritis ankle least stage 2 Kellgren Lawrence scale . Their AOFAS score 90 point less possible 100 point . Eligible subject willing discontinue pain medication NSAIDs rescue pain medication provide study . Persons systemic inflammatory condition infection ankle nearby soft tissue , injection steroid surgery involve joint within 6 month , local cellulitis , rash , skin condition diabetic neuropathic Charcot arthropathy , significant vascular insufficiency , current treatment anticoagulant , low extremity pain syndrome , sciatica , sprain , plantar fasciitis , significant ankle instability malalignment , know allergy component either injection , know suspect allergy bird bird product , disable degenerative joint disease ipsilateral hip , knee foot ineligible study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>hyaluronate</keyword>
	<keyword>hyaluronic acid</keyword>
	<keyword>viscosupplementation</keyword>
</DOC>